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Adiponectin (Acrp30) is an insulin-sensitizing hormone pro-
duced and secreted exclusively by adipose tissue. Confocal fluores-
cent microscopy demonstrated the colocalization of adiponectin
with the Golgi membrane markers p115, -COP, and the trans-
Golgi networkmarker, syntaxin 6. Treatment of cells with brefeldin
A redistributed adiponectin to the endoplasmic reticulum where it
colocalized with the chaperone protein BIP and inhibited secretion
of adiponectin demonstrating a requirement for a functional Golgi
apparatus for adiponectin release. Confocal fluorescentmicroscopy
also demonstrated a colocalization of endogenous adiponectin with
that of expressedGGA1myc (Golgi-localizing-adaptin ear homol-
ogy ARF-binding protein) but with no significant overlap between
adiponectin and the GGA2myc or GGA3myc isoforms. Consistent
with confocal fluorescent microscopy, transmission electron
microscopy demonstrated the colocalization of GGA1 with adi-
ponectin. Although GGA1 did not directly interact with the adi-
ponectin protein, the adiponectin enriched membrane compart-
ments of adipocytewereprecipitatedby aGST-GGA1cargobinding
domain (VHS) fusion protein but not with a GST-GGA2 VHS or
GST-GGA3 VHS fusion proteins. Moreover, co-expression of adi-
ponectin with a GGA1 dominant-interfering mutant (GGA1-VHS
GAT domain) resulted in amarked inhibition of adiponectin secre-
tion in both 3T3L1 adipocytes and HEK293 cells, whereas no inhi-
bitionwas detectedwith the truncatedmutants GGA2-VHSGATor
GGA3-VHSGAT.Moreover, co-expression of wild type GGA1 with
adiponectin enhanced secretion of adiponectin. Interestingly, lep-
tin secretion was unaffected by neither the wild type form or GGA1
mutant. Taken together these data demonstrate that the trafficking
of adiponectin through its secretory pathway is dependent onGGA-
coated vesicles.
Over the past several years many studies have documented that in
addition to being a fat storage depot, adipocytes are a bona fide endo-
crine tissue that secrete several hormones that control insulin sensitivity
and energy balance (1–3). In particular, adiponectin, also called adipo-
cyte complement-related protein of 30 kDa (Acrp30), adipoQ, GBP28,
and apM1, was originally isolated as a highly induced gene following
adipocyte differentiation (4). This hormone is secreted exclusively by
adipocytes (4–7) and functions in vivo as an insulin sensitizer (8–10),
reducing glucose production by the liver (11) and enhancing fatty acid
oxidation in skeletal muscle (10) through the activation of two distinct
receptor isoforms (12). These receptors mediate increased AMP-de-
pendent kinase activation (13–15) and peroxisome proliferating acti-
vated receptor- ligand activity (16).
Adiponectin serum levels inversely correlate with insulin resistance
in both in animals and humans (17–21) in contrast to that observed for
other adipokines such as tumor necrosis factor- and resistin (22–25).
Type 2 diabetic patients also display reduced levels of adiponectin (26–
29).Moreover, injection of purified adiponectin decreases glucose levels
in ob/ob, non-obese diabetic, or streptozotocin-induced diabetic mice
(9, 30).
Adiponectin is initially synthesized as pre-hormone with a classical
signal sequence that is cotranslationally removed as the protein trans-
locates into the lumen of the endoplasmic reticulum (4, 31). The
secreted protein consists of an amino-terminal collagen domain that
shares significant homology to collagen VIII and X (4, 6), a carboxyl-
terminal globular domain that is homologous to the complement factor
C1q (4, 5, 32), and the hibernation-regulated serum proteins, hib20,
hib25, and hib27 (5). The three-dimensional structure determined by
x-ray analysis also revealed that adiponectin shares significant homol-
ogy to tumor necrosis factor-, another adipocyte-secreted hormone
that is implicated in the induction of insulin resistance (32). However, in
serum adiponectin circulates as two forms, a lower molecular weight
trimer-dimer and a higher oligomeric molecular weight complex.
Recent studies have demonstrated that disulfide bond formation
through Cys-39 is essential for the assembly of the higher oligomeric
complexes (33).
The GGA2 proteins (for Golgi localizing  adaptin ear homology
domain ARF-binding protein) are a family of ubiquitously expressed
monomeric clathrin adaptors that mediate sorting at the trans-Golgi
network (TGN) of specific cargo in an Arf-dependent manner. There
are three different isoforms ofGGAproteins termedGGA1,GGA2, and
GGA3. These proteins have a modular structure consisting of an NH2-
terminal VHS (Vps27, Hrs, STAM) domain, and Arf-binding GAT
(GGA and TOM1) domain, a clathrin binding hinge region, and a
COOH-terminal -adaptin “ear” (GAE) domain. The VHS domain
binds acidic cluster-dileucine sorting signals present in the cytosolic
domain of transmembrane vesicle proteins (34, 35) such as themannose
6-phosphate receptor (36), sortilin (37), and -secretase (38). The GAT
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the hinge region recruits clathrin (39). The GAE region has been shown
to interact with accessory proteins including rabaptin-5 (43, 44), entho-
protin (45), -synergin (46), and with ubiquitin (47).
In the present study, we demonstrate that adiponectin in the steady
state is predominantly localized in a peri-nuclear compartment indis-
tinguishable from the Golgi apparatus/TGN. Consistent with the mor-
phological observations, secretion of adiponectin is severely inhibited
by treatment of cells with brefeldin A (BFA). Furthermore a dominant-
interferingmutant of theGGA1protein (GGA1VHSGATdomain)was
able to block both traffic of the GLUT4 glucose transporter to its insu-
lin-sensitive intracellular compartment and secretion of adiponectin
but did not affect leptin secretion. In addition, confocal and transmis-
sion electron microscopy studies showed colocalization of adiponectin
with the GGA1 isoform. These data suggest that adiponectin (but not
leptin) secretion is dependent on GGA proteins and suggest that GGA
adaptors participate in the regulation of selective adipokine trafficking
in adipocytes.
EXPERIMENTAL PROCEDURES
Materials—Brefeldin A and cycloheximide were obtained from
Sigma. Brefeldin A was prepared as a 5 mg/ml stock in methanol and
used at a final concentration of 5g/ml. Cycloheximidewas prepared as
a 10 mg/ml stock and used at a final concentration of 10 g/ml. Adi-
ponectin antibody was obtained as described previously (5). Antibodies
for syntaxin 6, p115, and BIP were from BD Biosciences. Antibody for
vesicular stomatitis virus-G (VSV-G) protein was obtained from Acu-
rate Biochemicals. Anti-myc and anti-GGA1 antibodies were from
Santa Cruz Biotechnology. Biotin-conjugated anti-myc antibody was
from Sigma. Antibody anti-GFP was from Roche Applied Science, Dul-
becco’s modified Eagle’s medium (DMEM), Opti-MEM I, fetal bovine
serum, calf serum, and trypsin were from Invitrogen. Lipofectamine
2000 was obtained from invitrogen. Radioimmunoassay kit for adi-
ponectin was obtained from Linco Research (St. Charles, MO). ELISA
kits for adiponectin and leptin were purchased from R&D Systems. The
GGA1, GGA2, and GGA3 wild type constructs and eGFP-VHS-GAT
domain were obtained from Dr. J. Bonifacino (National Institutes of
Health). A plasmid encoding for the VSV-G protein wild type protein
was a gift from Dr. M. McNiven (Mayo Clinic and Graduate School,
Rochester, MN).
Generation of DNA Constructs—The GST-GGA1 VHS-GAT, GST-
GGA2 VHS-GAT, and GST-GGA3 VHS-GAT constructs were gener-
ated by PCR amplification of the VHS-GAT domains of the wild type
forms of GGA1–3, followed by ligation into the GST-expressing vector
pGEX4T (Amersham Biosciences).
Cell Culture and Transient Transfection—3T3L1 cells were obtained
from the American Type Tissue Culture repository. Cells were cultured
in DMEM supplemented with 25 mM glucose, 10% calf serum at 37 °C
with 8%CO2. The cells were differentiated into adipocytes with 1g/ml
insulin, 1Mdexamethasone, and 0.5mM isobutyl-1-methylxanthine as
described previously (48). Differentiated adipocytes were electropo-
rated at 950microfarads and 0.15V, using aGene Pulse II electroporator
from Bio-Rad. Following electroporation cells were plated on collagen
IV-treated coverslips and allowed to recover in DMEM supplemented
with 10% Serum. HEK293 cells were cultured in minimal essential
medium containing 10% of FBS and penicillin/streptomycin at 37 °C
with 5% CO2. Cells were plated in 24-well plates and transfected using
Lipofectamine 2000 (Invitrogen) following the manufacturer’s
instructions.
Immunofluorescence and Image Analysis—Transfected and intact
adipocytes were washed in phosphate buffered saline (PBS) and treated
for 15minwith a solution containing 4%paraformaldehyde, 0.2%Triton
X-100, and 0.4% bovine serum albumin (BSA). Cells were then incu-
bated in blocking buffer containing 5% donkey serum (Sigma) and 1%
BSA for 1 h at room temperature. Primary and secondary antibodies, as
indicated in the figure legends to Figs. 1, 2, 4, and 7, were used at 1:100
dilution in blocking buffer. The cells were washed three times with PBS
andmounted on glass slides with Vectashield (Vector Laboratories) and
were imaged using a Zeiss LSM 510 META confocal microscope.
Images were then imported to Adobe Photoshop (Adobe Systems, Inc.)
for processing.
Temperature Block—After electroporation 3T3L1 adipocytes were
placed overnight in DMEMcontaining 10% fetal bovine serum at either 16
or 19 °C. Following an overnight incubation cells were fixed and permeabi-
lized as indicated above and processed for immunofluorescence.
Pull-down Assay and Western Blot Analysis—For the pull-down
assay, whole cell extracts were prepared in HES buffer: 30 mM Hepes,
pH 7.4, 1 mM EDTA, 250 mM sucrose) supplemented with 1 mM phen-
ylmethylsulfonyl fluoride, 10 g/ml aprotinin, 1 g/ml leupeptin, and 1
g/ml pepstatin. Cells were then homogenized in a Dounce homoge-
nizer (five times) and lysates centrifuged to 37,000 rpm for 10 min at
4 °C. Equal volumes of the supernatant were taken (1mg of protein) and
incubated with glutathione beads (GST or GST-GGA1VHS GAT) for
2 h at 4 °C. Samples were centrifuged briefly (13,000 rpm for 1min), and
the beads were washed three times with PBS. Pelleted samples were
eluted in 2 loading sample buffer. Samples were boiled for 5 min and
loaded onto a SDS-PAGE. Samples transferred to a nitrocellulosemem-
brane and immunobloted with an antibody specific for adiponectin.
Radioimmunoassays and ELISA—Fully differentiated cells were
trypsinized for 10 min and replated at equal densities into 12 well mul-
tidishes and were allowed to recover overnight in DMEM containing
10% FBS. Following an overnight incubation the medium was changed
to DMEMwithout serum supplementation, and at different time inter-
vals an aliquot of medium was collected for radioimmunoassay follow-
ing the manufacturer’s instructions (Linco Research). Similarly, ELISA
assays were performed on aliquots of medium taken 24–30 h following
transfection. Prior to radioimmunoassay/ELISA floating cells were
removed by centrifugation at 500  g for 5 min and the supernatant
used for the radioimmunoassay/ELISA quantification. In parallel an ali-
quot of the whole cell lysate was also quantified.
Transmission Electron Microscopy—HEK293 cells were collected by
trypsinization (5 min) followed by inactivation of trypsin with 10% FBS
medium. Cells were then centrifuged and washed twice with PBS. Pel-
leted cells were fixed in 2% parafolmaldehyde, 0.2% glutaraldehyde for
24 h at 4 °C. Cells were dehydrated in ascending alcohol series (50–
100%) 15min each and infiltrated in LRWhite resin overnight. Samples
were then cured at 50 °C for 48 h, sectioned, and mounted on nickel
grids. Following aldehyde quenching with 50 mM glycine, for 30 min,
samples were incubated in a blocking solution containing 5% donkey
serum and 1% BSA for 1 h at room temperature. Immunolabeling with
specific primary antibodies at 1:100was done overnight at 4 °C. Samples
were washed three times with PBS and secondary antibodies (goat anti-
rabbit IgG 25-nm gold and goat anti-mouse IgG 10-nm gold) were
added at 1:50 for 2 h at room temperature. Samples were washed in PBS
and water and visualized in a FEI CM100 microscope.
Statistical Analysis—One-way ANOVA was performed using SAS
statistical software.
RESULTS
Intracellular Localization of Adiponectin in 3T3L1 Adipocytes—To
characterize the intracellular localization of adiponectin, we examined
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the distribution of adiponectin with several intracellular markers. The
endogenous adiponectin protein (Fig. 1, a, d, and g) was primarily local-
ized in the peri-nuclear compartment as well as some scattered vesicle
staining throughout the cytoplasm. The peri-nuclear distribution over-
lappedwithGolgimarkers p115 (Fig. 1, a–c), syntaxin 5 (Fig. 1, d–f), and
-COP (data not shown) and the TGN marker syntaxin 6 (Fig. 1, g–i).
We further confirmed the Golgi localization of adiponectin by using
reduced temperature to block secretory protein trafficking. VSV-G pro-
tein is a membrane protein in the constitutive secretory pathway that
accumulates in the endoplasmic reticulum at 16 °C and in the Golgi
complex at 19 °C (49). Incubation of cells at 16 °C immediately following
transfection resulted in a diffuse intracellular labeling ofVSV-Gprotein,
consistent with the endoplasmic reticulum distribution in these cells
(Fig. 2A, panel a). At 19 °C, VSV-G protein displayed a predominant
peri-nuclear distribution consistent with Golgi localization (Fig. 2,
panel b). To ensure that the temperature block did not damage the cells
and thereby resulted in an aberrant accumulation in theGolgi, following
incubation at 19 °C the cells were shifted to 37 °C for 1 h (Fig. 2A, panel
c). Under these conditions, the VSV-G protein was fully capable of
exiting the Golgi and traffic to the plasma membrane. In parallel, at
19 °CVSV-Gprotein colocalizedwith endogenous adiponectin (Fig. 2B,
panels d–f).
BFA is a fungal metabolite that inhibits guanylnucleotide exchange
factors that act on class I Arf GTP-binding proteins (50). This inhibition
results in a block of anterogradeGolgi trafficking and thereby causes the
collapse of the Golgi stacks back into the endoplasmic reticulum (51,
52). We next determined the effect of BFA on adiponectin secretion by
radioimmunoassay (Fig. 3A). In control cells, there was a constitutive
secretion of adiponectin into the medium that was relatively linear over
the time course examined (Fig. 3A). Treatment with BFA completely
blocked the release of adiponectin, whereas the protein synthesis inhib-
itor, cycloheximide, had no effect (Fig. 3A). Identical results were
obtained when the incubationmediumwas assayed by immunoblotting
(data not shown). Furthermore, cycloheximide treatment for 2 h did not
alter the distribution of intracellular endogenous adiponectin in 3T3L1
adipocytes, which remained associatedwith theGolgimarkers (Fig. 3B).
As a control for cycloheximide action, HEK293 cells were transfected
with a vector coding for a green fluorescent protein. Immediately fol-
lowing transfection a subset of cells were treated with cycloheximide.
Imaging of these cells revealed no reporter gene expression in the cells
treated with the drug (Fig. 3C).
FIGURE 1. Localization of endogenous adiponectin in the Golgi/TGN. Fully differen-
tiated adipocytes were fixed, permeabilized, and immunostained with a specific poly-
clonal antibody specific for adiponectin (panels a, d, and g) or with the cis-Golgi markers
p115 (panel b) and syntaxin 5 (panel e), or with the trans-Golgi network marker syntaxin
6 (panel h). The merged images are shown in the right panels. The yellow color in the
merged images (panels c, f, and i) indicates colocalization. Images were obtained using a
Zeiss 510 META confocal microscope.
FIGURE 2. Adiponectin colocalizes with the vesicular stomatitis virus G protein. A,
temperature block of the VSV-G protein. Fully differentiated adipocytes were electropo-
rated with a construct coding for the vesicular stomatitis virus protein. After electropo-
ration cells were incubated overnight at 16 °C (panel a), overnight at 19 °C (panel b), or
incubated overnight at 19 °C and then placed at 37 °C for 1 h prior to analysis (panel c).
Following these incubations cells were fixed, permeabilized, and immunostained with
an antibody specific for VSV-G protein obtained from Acurate Biochemicals, Inc., as
described under “Experimental Procedures.” Images were obtained using a Zeiss 510
META confocal microscope. B, colocalization of endogenous adiponectin and VSV-G
protein. Fully differentiated adipocytes were electroporated with a construct coding for
the vesicular stomatitis virus G protein. After electroporation cells were incubated over-
night at 19 °C. The next day, cells were fixed, permeabilized, and immunostained with an
antibody specific for VSV-G protein (panel d) or with an antibody specific for adiponectin
(panel e) as described under “Experimental Procedures.” Panel d shows GFP VSV-G pro-
tein. The yellow color in the merged image (panel f) indicates colocalization. Images were
obtained using a Zeiss 510 META confocal microscope. IF, immunofluorescence.
FIGURE 3. Secretion of adiponectin is inhibited by brefeldin A but not by cyclohex-
imide. A, time course of adiponectin secretion. Fully differentiated adipocytes were
replated in 12-well dishes with the same cell density and allowed to recover in DMEM
with 10% FBS. 24 h later, medium was changed to DMEM without serum, in the absence
of drug (No treatment), in the presence of 5 g/ml brefeldin A, (Brefeldin A), or in the
presence of 10 g/ml cycloheximide (Cycloheximide). A small aliquot of medium was
taken at the indicated times, spun for 5 min at 3000 rpm, and the supernatant collected
to determine the amount of adiponectin by radioimmunoassay (RIA). B, Golgi prepara-
tion of 3T3L1 adipocytes. Differentiated adipocytes were left untreated or treated with
10 g/ml cycloheximide (CHX) for 2 h at 37 °C. Following this time, cells were fractionated
and the Golgi membranes purified as described under “Experimental Procedures.” Equal
amounts of the total lysate or the purified Golgi fraction were loaded onto a SDS-PAGE
and immunobloted with the indicated specific antibodies. A representative blot of three
independent experiments is shown. H, homogenate. C, cycloheximide inhibits the
expression of the green fluorescent reporter gene ARF-1 GFP. HEK293 cells were trans-
fected with a construct coding for a GFP-tagged ARF-1 protein. Immediately after trans-
fection cycloheximide (CHX) was added to group of cells, whereas a group of cells were
left untreated (CHX). Following the treatment with the drug, images of cells were taken
on a NIKON TE2000 microscope on a fluorescein isothiocyanate (FITC) or brightfield
setting.
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Adiponectin Colocalizalizes with GGA Isoforms—Since adiponectin
was localized in the Golgi/TGN region at steady state in 3T3L1 adipo-
cytes we postulated that adaptor proteins at the TGN could regulate
adiponectin secretion in adipocytes. GGA proteins are molecular adap-
tors that mediate sorting at the TGN of specific cargo vesicles and
recruit clathrin in an Arf-dependent manner. Recent reports have doc-
umented that GGA adaptors facilitate transport of the glucose trans-
porter GLUT4 to the insulin-sensitive compartment in adipocytes (53,
54). To investigate whether GGA coat adaptors are involved in adi-
ponectin secretion, we first examined the colocalization of the GGA
isoforms with endogenous adiponectin by confocal microscopy imag-
ing. This was performed in adipocytes that expressed the wild type
forms of either GGA1myc, GGA2myc, or GGA3myc. Double staining
was performed as indicated under “Experimental Procedures” using a
myc antibody and an antibody specific for adiponectin (Fig. 4, A–C).
As shown in Fig. 4A, panel b, expressed GGA1myc displayed a
perinuclear localization that substantially overlapped with that of
endogenous adiponectin (Fig. 4A, panel c). Similar distributions
were observed for GGA2myc (Fig. 4B, panel b) and GGA3myc (Fig.
4C, panel c) isoforms. Interestingly, insulin treatment of the cells for
30 min had no significant effect on the distribution of either adi-
ponectin nor the expressed GGA isoforms (Fig. 4A, panel f and Fig.
4B, panel f). Overall, these results demonstrate that GGA proteins
broadly colocalized with endogenous adiponectin and suggest that
GGA adaptors may be involved in the trafficking of adiponectin
from Golgi/TGN compartments.
To further confirm these studies, we next examined the localization
of endogenous adiponectin and endogenous GGA1 in isolated mouse
adipocytes and the localization of expressed adiponectin and GGA1-
VHS-eGFP in HEK293 cells by transmission electron microscopy (Fig.
5). In isolated fat tissue, immunogold labeling of adiponectin (10-nm
gold) and GGA1 (25-nm gold) indicated that these proteins were in
close proximity (Fig. 5, A and B). Similar results were obtained in
HEK293 cells expressing adiponectin (25-nm gold particles) and
GGA1-VHS (10-nm gold particles), where both proteins were primarily
confined to the perinuclear region (Fig. 5, C and D). Although we were
unable to preserve a high degree of membrane morphology, higher
magnification clearly demonstrated that the GGA1 positive gold parti-
cles were colocalizedwith the adiponectin-positive gold particles (Fig. 5,
B and D).
Unfortunately, the lack of suitable GGA2- and GGA3-specific anti-
bodies prevented us from examining the colocalization of these proteins
with endogenous adiponectin in electron microscopy studies. To fur-
ther characterize the interaction between adiponectin-containing vesi-
cles and the different GGA isoforms, we designed biochemical and
functional assays, which are detailed below.
To investigate whether recombinant GGA proteins could bind to
adiponectin-containing vesicles in vitro, we next generated constructs
expressing the cargo binding domain (VHS) and Arf binding domain
(GAT) of eitherGGA1,GGA2, orGGA3proteins fused in frame toGST
(GST-GGA1VHSGAT, GST-GGA2VHSGAT, or GST-GGA3VHS-
GAT) and performed in vitro pull down assays. Adiponectin vesicles
FIGURE 4. Colocalization of GGA proteins and endogenous adiponectin inadipo-
cytes. Fully differentiated adipocytes were electroporated with a construct coding for
the wild type form of GGA1 myc (A), GGA2myc (B), or GGA3myc (C). Following an over-
night incubation to allow for protein expression, cells were fixed, permeabilized, and
stained as indicated under “Experimental Procedures” with an antibody specific for adi-
ponectin (panels a and d) and an antibody for myc (panels b and c). When indicated a
subset of cells was treated with 100 nM insulin for 30 min prior to fixation. Confocal
imaging was performed in a Zeiss 510 META confocal microscope. The yellow color in the
merged images (panels c and f) indicates colocalization. Shown are representative cells
of three independent experiments.
FIGURE 5. Colocalization of GGA proteins and adiponectin. A and B, isolated mice
adipocytes were fixed and processed for electron microscopy as indicated under “Exper-
imental Procedures.” Immunolabeling was performed with an antibody against adi-
ponectin and antibody against GGA1 (Santa Cruz Biotechnology). Secondary antibodies
were: goat anti rabbit IgG 10-nm gold for adiponectin and donkey anti-goat IgG 25-nm
gold for GGA1. Samples were visualized in a FEI CM100 transmission electron micro-
scope. The arrows indicate colocalization of the two proteins. C and D, HEK293 cells were
cultured and cotransfected with a vector expressing adiponectin-myc and either the
GGA1 VHS-GFP. 24 h following transfection cells were processed for transmission elec-
tron microscopy as described under “Experimental Procedures.” Immunolabeling was
performed with an antibody against adiponectin and antibody against GFP (Roche
Applied Science). Secondary antibodies were: goat anti rabbit IgG 25-nm gold for adi-
ponectin and goat anti-mouse IgG 10-nm gold for GFP. Samples were visualized in a FEI
CM100 transmission electron microscope. The arrows indicate colocalization of the two
proteins.
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from adipocyte lysates could be effectively precipitated with recombi-
nant GST GGA1-VHSGAT immobilized to glutathione-Sepharose
beads (Fig. 6A, lane 2, but not with GST alone (Fig. 6A, lane 1). This was
specific for the GGA1 VHS-GAT domain as neither the GGA2 nor
GGA3 VHS-GAT domains were capable of precipitating adiponectin-
containing compartments (Fig. 6A, lanes 3 and 4). Precipitation of adi-
ponectin by recombinant GST-GGA1VHSGAT occurred in the
absence of detergent (Fig. 6B, lane 2), but there was no precipitation of
adiponectin in the presence of detergent (Fig. 6B, lane 4). Although the
amount of adiponectin precipitated by GST GGA1-VHS was relatively
small compared with the total amount of adiponectin present (Fig. 6, A
and B, lane 2), these data demonstrated that GGA1 can interact with
adiponectin-containing compartments but not directly with adiponec-
tin itself.
A Dominant-interfering Mutant of GGA1 Blocks Adiponectin
Secretion—We next investigated whether GGA proteins are involved in
the cargo selection of adiponectin-containing vesicles in 3T3L1 adipo-
cytes. Expression of GLUT4 in adipocytes resulted in the typical perinu-
clear localization of this protein and insulin-stimulated the transloca-
tion of GLUT4 to the plasma membrane (Fig. 7A, panels a and f).
Co-expression of the dominant-interfering GGA1 mutants (VHS
domain) had no apparent effect on GLUT4 localization but markedly
inhibited the insulin-stimulated translocation of the newly synthesized
GLUT4 protein (Fig. 7A, panels b, c, g, and h). As a control, co-expres-
sion of the full-length GGA1 protein had no significant effect on the
basal or insulin-stimulated translocation of GLUT4 (Fig. 7A, panels d, e,
i, and j). These data are consistent with previous data demonstrating
that the expression of a dominant-interferingGGA1mutant inhibits the
insulin-stimulated translocation of the newly synthesized GLUT4
protein (53).
To assess the functional effect of the GGA1 VHS domain on adi-
ponectin secretion, 3T3L1 adipocytes (Fig. 7B) orHEK293 cells (Fig. 7C,
open bars) were cotransfectedwith a construct expressing amyc-tagged
adiponectin protein and various control and GGA mutants. The
expressed adiponectin-myc protein displayed a perinuclear localization
(Fig. 7D, panel a) that overlapped with that of the Golgi localized GFP-
tagged ADP-ribosylating factor (ARF-1 GFP) (Fig. 7D, panels b and c).
Expression of the full-length GGA1 protein had no significant effect on
adiponectin-myc secretion in 3T3L1 adipocytes (Fig. 7B), whereas a
small reproducible enhancement of adiponectin secretionwas observed
inHEK293 cells comparedwith cells transfectedwith adiponectin alone
or cells transfected with adiponectin and an irrelevant protein, GLUT1
(Fig. 7C). In contrast, expression of the GGA1VHSGAT domain inhib-
ited adiponectin secretion in both cell types. The inhibitory action of
GGA1VHSGAT was specific, as the VHSGAT domains of GGA2 and
GGA3 were without affect (Fig. 7, B and C). Moreover, the
GGA1VHSGAT domain had no significant effect on the secretion of
leptin (Fig. 7C, filled bars). Taken together, these data support a model
in which adiponectin secretion is specifically dependent upon GGA1
function.
DISCUSSION
Adiponectin increases energy expenditure and decreases circulating
glucose and fatty acid levels without a reduction in food uptake (9, 10,
30). Based upon the central role that adiponectin plays in the control of
metabolism, energy homeostasis, and insulin sensitivity, we elected to
study the secretorymembrane trafficking pathways that are responsible
for the release of this adipokine from adipocytes. Confocal microscopy
studies in 3T3L1 adipocytes showed that adiponectin was mostly dis-
tributed to the perinuclear region, with some punctuate staining
throughout the cytoplasm. The adiponectin perinuclear distribution
stained positive for markers of the Golgi/TGN, such as p115 and syn-
taxin 6, whereas no colocalization was detected with endosomal mark-
ers or endoplasmic reticulum markers (data not shown). In addition,
temperature blocks at 19 °C showed colocalization of endogenous adi-
ponectin with the VSV-G protein, which at this temperature is trapped
specifically in the TGN. Thus, our data support the hypothesis that a
substantial amount of adiponectin in the steady state is located in the
Golgi/TGN. Another study had previously reported that adiponectin-
containing transport vesicles partially overlap with the endoplasmic
reticulum marker GRP94 (56). Although we do not know the basis for
these differences, consistent with adiponectin transport through the
Golgi complex, brefeldin A completely blocked adiponectin secretion,
indicating that a functional Golgi apparatus is required for adiponectin
secretion.
It is well established that traffic through the Golgi requires the
recruitment of coat proteins on Golgi membranes, through a process
regulated by members of the ADP-ribosylation factors (Arf) family of
small GTP-binding proteins (39, 42, 58). These factors recruit adaptor
molecules that in turn recruit clathrin to the nascent vesicles. To exam-
ine what other elements are required for the trafficking of adiponectin-
containing vesicles, we examined the role of the coat adaptor GGA
proteins. Recently it has been reported that these proteins mediate the
sorting of GLUT4-containing vesicles into the insulin-responsive stor-
age compartment in 3T3L1 adipocytes (53, 54).
To examine whether this interaction between GGA and adiponectin
occurs in vivo, we transfected fully differentiated adipocytes with either
GGA1myc, GGA2myc, or GGA3myc constructs and analyzed by con-
focal microscopy whether endogenous adiponectin colocalized with
these GGA proteins. Our results showed that expressed GGA proteins
exhibited a substantial degree of colocalization with that of endogenous
adiponectin in differentiated 3T3L1 cells. Transmission electron
microscopy studies also confirmed localization of GGA1 adaptor pro-
teins with adiponectin in mouse adipocytes.
Structural analysis of GGA proteins has showed differences in the
VHS domains of GGA1 and GGA2, with GGA2 having a more flexible
and unwound 6 helix end (55), and this can contribute to the recogni-
FIGURE 6. Recombinant GGA1, but not GGA2 or GGA3, binds to adiponectin-con-
taining vesicles. A, a GST alone or a GST fusion protein with the VHS-GAT domain of
either GGA1, GGA2, or GGA3 was produced in bacteria, purified, and bound to glutathi-
one beads as indicated under “Experimental Procedures.” Whole cell lysates obtained
from fully differentiated 3T3L1 adipocytes were incubated with either the GST or GST-
GGA1/2/3-VHS-GAT fusion proteins for 2 h at 4 °C. Following this incubation the bound
material (pellets) and the non-bound material (SN) were separated by brief centrifuga-
tion, the pellets washed, and the samples loaded onto an SDS-PAGE for immunoblotting
with a specific antibody against adiponectin. A representative blot of five independent
experiments is shown. B, whole cell lysates obtained from fully differentiated 3T3L1
adipocytes were incubated with either GST or GST-GGA1VHS-GAT fusion protein for 2 h
at 4 °C in the absence of detergent (lanes 1 and 2) or in the presence of 1% Triton X-100
(lanes 3 and 4). Following this incubation the bound material (pellets) and the non-bound
material (SN) were separated by brief centrifugation, the pellets washed, and the sam-
ples loaded onto an SDS-PAGE for immunoblotting with a specific antibody against
adiponectin. A representative blot of three independent experiments is shown.
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tion of distinct cargo vesicles. While evidence exists that insulin
enhances secretion of adiponectin (5, 56), we did not observe any
change in the degree of colocalization between GGA and adiponectin
following the treatment of cells with insulin. This would suggest that the
pool of adiponectin under investigation here is constitutively secreted.
Alternatively, insulin may act through a distal (post-TGN) target com-
partment. Further studies are needed to determine the site of insulin
action that results in enhanced adiponectin secretion in adipocytes.
Nevertheless, using GGA precipitation assays, we observed an inter-
action of the GGA1 VHSGAT domain with adiponectin-containing
transport compartments. This binding was specific, since no separation
was achieved using the GST portion only or GST fusions with the other
GGA isoforms. Importantly, GGA1 did not directly interact with the
GGA1 protein but indirectly associated with the adiponectin-contain-
ing transport compartments. This is consistent with the known topol-
ogy of the GGA proteins (cytosolic) and adiponectin (intraluminal) and
further indicates that the adiponectin transport vesicles also contain a
specific GGA1 target protein necessary for appropriate cargo selection.
At present, the identity of this protein is unknown, and further work is
needed to determine which additional proteins participate in the GGA-
coating of adiponectin vesicles.
In addition to the ability of GGA1 to associate with adiponectin-
containing compartments, expression of the dominant-interfering
GGA1 mutant that contains the vesicle binding domain VHS-GAT
inhibited adiponectin secretion. This again was specific for GGA1, as
the same domains in GGA2 and GGA3 were without affect. GGA1
function was also specific for adiponectin secretion as another adipo-
kine, leptin, was not affected by expression of the dominant-interfering
GGA1 mutant. Interestingly, we also found that expression of full-
length wild type GGA1 protein enhanced adiponectin release in
HEK293 cells but not in differentiated 3T3L1 adipocytes, which sug-
gests that the amount of GGA1 protein in HEK293 cells may be rate-
limiting for adiponectin secretion in these cells.
In summary, our microscopy biochemical and functional data
strongly suggest thatGGAcoat adaptors regulate selective cargo forma-
tion at the TGN of adipocytes. While intracellular traffic and secretion
of adiponectin is mediated by GGA1-coated vesicles, leptin secretion is
independent of GGA adaptors. Further studies will now be needed to
determine whether GGA-mediated adiponectin secretion is a direct
plasma membrane secretory pathway, independent of the recycling
endosome system, and to identify other protein components that par-
ticipate in the generation of adiponectin-containing vesicles.
FIGURE 7. A, the VHS domain of GGA1 act as a dominant negative inhibiting Glut4 translocation in response to insulin. Fully differentiated adipocytes were co-electroporated with a
construct coding for the myc tag Glut4 glucose transporter and the empty vector pcDNA3.1 (panels a and f) or the vector coding for the glucose transporter Glut4myc and a construct
expressing the VHS and GAT domains of GGA1 fused to eGFP (panels b, c, g, and h) or the vector encoding for the glucose transporter glut4 fused to eGFP (Glut4eGFP) and a construct
coding for the wild type form of GGA1 (GGA1myc) (panels d, e, i, and j). Following electroporation cells were allowed to recover for 24 h and incubated in DMEM without serum or for
2 h at 37 °C. A subset of cells was then stimulated with 100 nM insulin for 30 min at 37 °C. Following these incubations cells were fixed, permeabilized, and immunostained with an
antibody specific against the myc epitope (panels a, b, e, f, g, and j). Images were obtained using a Zeiss 510 confocal microscope. B, the VHS domain of GGA1 inhibits adiponectin
secretion in 3T3L1 adipocytes. Differentiated 3T3L1 adipocytes were cultured and co-electroporated with a vector expressing adiponectin-myc, a vector expressing adiponectin-myc
and the wild type GGA1 construct, or the adiponectin-myc vector and a construct coding for the corresponding dominant-interfering mutant (VHS-GAT domains) of each GGA protein
(GGA1-VHS, GGA2-VHS, GGA3-VHS). 24 –36 h following transfection medium and whole cell lysates were obtained, and an aliquot was quantified by ELISA as described under
“Experimental Procedures.” Secreted adiponectin (expressed as percent of total adiponectin expressed)  S.E. is represented from three independent experiments. Each experiment
was performed in triplicate, and each sample was quantitated in duplicate. Expression of GGA proteins was confirmed by Western blot analysis (data not shown). To detect only the
adiponectin expressed in the cells, for this ELISA we utilized an anti-adiponectin antibody as a capture antibody and a biotin labeled anti-myc antibody as a detection antibody.
Statistical analysis: a one-way ANOVA was utilized to determine significance. The adiponectin  empty vector control was utilized as a reference. Significance was considered if p 
0.001 and is indicated by an asterisk. C, the VHS domain of GGA1 inhibits adiponectin secretion but not leptin secretion in 293 cells. 293 cells were cotransfected with a vector
expressing adiponectin-myc and either an empty vector, a irrelevant protein (the glucose transporter GLUT1), a construct coding for GGA1 wild type (GGA1 WT), or a vector coding
vector for the corresponding dominant-interfering mutant (VHS-GAT domains) of each GGA protein (GGA1-VHS, GGA2-VHS, GGA3-VHS). An independent set of cells was transfected
with a construct expressing full-length of leptin and either an empty vector or a construct coding for GGA1 wild type or the dominant-interfering mutant of GGA1 mutant, which
contains only the VHS-GAT domain. 24 –36 h following transfection medium and whole cell lysates were obtained and an aliquot quantified by ELISA as described under “Experi-
mental Procedures.” Secreted adiponectin (expressed as percent of total adiponectin expressed)  S.E. is represented from three independent experiments. Expression of GGA
proteins was confirmed by Western blot analysis (data not shown). For this ELISA we utilized an adiponectin (or leptin) capture and detection antibodies, respectively. A one-way
ANOVA was utilized to determine significance. The adipokine  empty vector control was utilized as a reference. Significance (asterisk) was considered if p  0.001. D, adiponectin-
myc localizes to a perinuclear compartment in 3T3L1 adipocytes. Adipocytes were transfected with a construct coding for myc-tagged adiponectin (adiponectin-myc) and a construct
coding for the GFP-labeled ADP-ribosylating factor-1 protein (ARF-1 GFP). Cells were allowed to recover and the next day were fixed, permeabilized, and immunostained with an
antibody for anti-myc (panel a) and a secondary antibody conjugated to Texas Red. Panel b shows ARF-1 GFP. Images were obtained using a Zeiss 510 META confocal microscope.
Panel c shows the merged image.
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